Works matching IS 01145916 AND DT 2021 AND VI 44 AND IP 1

Results: 12

Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 95, doi. 10.1007/s40264-020-01035-x

By:

Beyzarov, Elena;
Chen, Yan;
Julg, Rob;
Naim, Karen;
Shah, Jigna;
Gregory, William W.;
Ayoub, Ayman;
Caubel, Patrick

Publication type:

Article

Efficacy and Safety of Bevacizumab Plus Oxaliplatin- or Irinotecan-Based Doublet Backbone Chemotherapy as the First-Line Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 29, doi. 10.1007/s40264-020-00997-2

By:

Ren, Tianshu;
Wang, Shu;
Shen, Zexu;
Xu, Chang;
Zhang, Yingshi;
Hui, Fuhai;
Qi, Xingshun;
Zhao, Qingchun

Publication type:

Article

ADE Eval: An Evaluation of Text Processing Systems for Adverse Event Extraction from Drug Labels for Pharmacovigilance.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 83, doi. 10.1007/s40264-020-00996-3

By:

Bayer, Samuel;
Clark, Cheryl;
Dang, Oanh;
Aberdeen, John;
Brajovic, Sonja;
Swank, Kimberley;
Hirschman, Lynette;
Ball, Robert

Publication type:

Article

Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 73, doi. 10.1007/s40264-020-00995-4

By:

Hoeve, Christina E.;
de Vries, Esther;
Mol, Peter G. M.;
Sturkenboom, Miriam C. J. M.;
Straus, Sabine M. J. M.

Publication type:

Article

Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 63, doi. 10.1007/s40264-020-00993-6

By:

Francisca, Reynold D. C.;
Baba, Emna;
Hoeve, Christina E.;
Zomerdijk, Inge M.;
Sturkenboom, Miriam C. J. M.;
Straus, Sabine M. J. M.

Publication type:

Article

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 7, doi. 10.1007/s40264-020-01007-1

By:

Simbrich, Alexandra;
Thibaut, Jasmine;
Khil, Laura;
Maximov, Stanislav;
Wiendl, Heinz;
Berger, Klaus;
for the REGIMS Investigators;
Klotz, Luisa;
Stögbauer, Florian;
Aktas, Orhan;
Ziemssen, Tjalf;
Zipp, Frauke;
Bayas, Antonios;
Müller, Thomas;
Paul, Friedemann;
Seipelt, Maria;
Angstwurm, Klemens;
Weber, Martin;
Wildemann, Brigitte;
Kümpfel, Tania

Publication type:

Article

Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort Study.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 53, doi. 10.1007/s40264-020-00992-7

By:

Mathieu, Clément;
Joly, Pierre;
Jacqmin-Gadda, Hélène;
Wanneveich, Mathilde;
Bégaud, Bernard;
Pariente, Antoine

Publication type:

Article

Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 41, doi. 10.1007/s40264-020-00987-4

By:

Mehta, Ushma;
Smith, Mariette;
Kalk, Emma;
Hayes, Helen;
Swart, Annoesjka;
Tucker, Lawrence;
Coetzee, Renier;
Boulle, Andrew;
Blockman, Marc

Publication type:

Article

Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 107, doi. 10.1007/s40264-020-01022-2

By:

Trumbo, Henry;
Kaluza, Karolina;
Numan, Syed;
Goodnough, Lawrence T.

Publication type:

Article

How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.

Published in:

2021

By:

Shakir, Saad;
Lane, Samantha;
Davies, Miranda

Publication type:

Editorial

Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 17, doi. 10.1007/s40264-020-01008-0

By:

Peters, Tanja;
Soanes, Nigel;
Abbas, Maya;
Ahmad, Jabeen;
Delumeau, Jean-Christophe;
Herrero-Martinez, Esteban;
Paramananda, Mélanie;
Piper, Johanna;
Smail-Aoudia, Fairouz;
van der Spuij, Willemijn;
Veizovic, Tina;
Winstanley, Gillian

Publication type:

Article

Follow-up on the Use of Advanced Analytics for Clinical Quality Assurance: Bootstrap Resampling to Enhance Detection of Adverse Event Under-Reporting.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 121, doi. 10.1007/s40264-020-01011-5

By:

Koneswarakantha, Björn;
Barmaz, Yves;
Ménard, Timothé;
Rolo, Donato

Publication type:

Article